Why IGF-1 comes up
IGF-1 stands for insulin-like growth factor 1. It helps mediate growth hormone’s effects, and its blood concentration is more stable across the day than growth hormone itself. That makes it useful in evaluating and monitoring certain growth hormone disorders, according to MedlinePlus.
But useful does not mean self-interpreting. A laboratory value has to be read alongside the reason for testing, your history, the laboratory’s reference range, and other findings. The same number can prompt different questions in different clinical settings.
When a clinic advertises “optimization,” ask what it means in practice. A target should have a clinical rationale. A number that looks impressive on a dashboard is not automatically a sensible treatment goal.
A low result is not a complete diagnosis
The Endocrine Society’s adult growth hormone deficiency guideline says confirmation with stimulation testing is usually necessary, with specific exceptions. Its hypopituitarism guidance also explains that a single growth hormone measurement is not helpful for diagnosis.
The full adult guideline notes that conditions such as poorly controlled diabetes or liver disease, and oral estrogen therapy, can complicate interpretation of low IGF-1. A clinician needs that context before deciding what the result means.
This is especially relevant when fatigue or changing body composition is the reason for seeking care. Those concerns deserve evaluation, but starting with a desired prescription can narrow the discussion too early. Ask which possible explanations are being considered and why a hormone disorder is suspected.
Separate three different questions
| Question | What you want the clinician to explain |
|---|---|
| Do I have a growth hormone disorder? | How history, examination, laboratory findings, and any specialist testing fit together. |
| Is the medication affecting hormone biology? | What a change in IGF-1 means under your treatment plan. |
| Am I benefiting overall? | Whether the outcome you care about improved enough to justify risks, costs, and inconvenience. |
These questions can overlap without becoming interchangeable. For example, a follow-up value may change while the symptom that led you to seek treatment remains unchanged. That should trigger a conversation about the original goal, rather than automatic escalation to pursue a higher value.
Build a monitoring plan before paying
Ask your prescriber which tests are appropriate, why each is being ordered, when results will be reviewed, and what findings would change the plan. Request the expected costs at the same time. A membership that includes clinician access may still charge separately for laboratory services.
- Who orders the bloodwork and which laboratory can you use?
- Who interprets results, and will you receive a written explanation?
- What happens if a result is outside the expected range?
- How will symptoms and adverse effects be reviewed alongside numbers?
- What would lead to stopping or reconsidering treatment?
There is no universal testing calendar supplied by this article. A schedule copied from another patient or an online protocol may not match your medical circumstances. Likewise, recommendations for growth hormone replacement in diagnosed deficiency should not be presented as a validated protocol for compounded sermorelin wellness treatment.
Read your own report carefully
Keep the original report, including units, the laboratory reference interval, and collection date. Ask whether a comparison with an older result is meaningful if the laboratory or method changed. Avoid comparing a bare number with someone else’s social-media screenshot.
Follow the ordering clinician’s preparation instructions for the complete set of tests. Even if one test needs no special preparation, another test collected at the same visit may have different requirements. Tell the clinician about your medications and supplements rather than stopping them on your own.
If you are already taking sermorelin, do not adjust the dose to move a result into a preferred part of the range. Ask the prescriber to explain the result and any proposed change in the context of your symptoms and risks.
Our evidence guide explains why a biomarker and a meaningful outcome need separate evaluation. The insurance and budgeting guide helps you check who pays for testing before it becomes a surprise charge.
Sources & further reading
Sources reviewed October 2026. Provider prices and terms may change.